Latest Iconovo News & Updates

See the latest news and media coverage for Iconovo. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Iconovo

Inhalation medicine development company

iconovo.se
Headquarters
Lund, Sweden
Founded year
2013
Company type
Public company
Number of employees
20–50

Last updated

Latest news about Iconovo

In short: Iconovo appointed Anders Månsson as permanent CEO, secured significant patent progress for ICOpre, and raised approximately $50 million in capital.

Company announcements

Iconovo

Iconovo calls annual general meeting

The meeting is held on 28 May 2026 in Lund. Proposed board election, incentive programme with options and authorisation for issuance.

Iconovo

Iconovo publishes Q1 2026 quarterly report

Reports net sales of 675 TSEK, operating loss of -7,996 TSEK, share issues raising MSEK 49.6, patent progress for ICOpre®, and LOI with Lonza.

Unlock all announcements with a

Media coverage

FinanzNachrichten

Iconovo AB: Quarterly Report Q1 2026

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2026In January 2026, it was announced that the European Patent Office (EPO) had declared its intention to...

FinanzNachrichten

Iconovo AB: Anders Månsson is appointed CEO

Iconovo AB (publ) has today appointed Anders Månsson as permanent CEO of Iconovo AB after approximately 6 months of service as interim CEO. Anders Månsson...

FinanzNachrichten

Iconovo AB: Iconovo publishes preliminary outcome of rights issue and announces recalculation of warrants series TO 1

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN...

Unlock all articles with a

Never miss news about Iconovo

Track Iconovo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.